加紧扩大规模_老虎社区_美港股上老虎 - 老虎社区

加紧扩大规模

Tempus AI Launches AI Powered Prostate Cancer Risk Test<blockquote>腾邦AI推出AI驱动的前列腺癌风险测试</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

1

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":566825178612568,"tweetId":"566825178612568","gmtCreate":1779419368265,"gmtModify":1779419370711,"author":{"id":3522050789531005,"idStr":"3522050789531005","authorId":3522050789531005,"authorIdStr":"3522050789531005","name":"Madagascar P","avatar":"https://static.tigerbbs.com/55bfe47a562a9809d5f55b450b1d221c","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":6,"crmLevelSwitch":1,"currentWearingBadge":{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.12.20","individualDisplayEnabled":0},"individualDisplayBadges":[],"wearingBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","name":"明星虎友","description":"加入老虎社区2000天","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","isScarce":0,"effectEnabled":0,"redirectLinkEnabled":0,"redirectLinkValidityFrom":0,"redirectLinkValidityTo":9223372036854776000}],"fanSize":21,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p>加紧扩大规模</p></body></html>","htmlText":"<html><head></head><body><p>加紧扩大规模</p></body></html>","text":"加紧扩大规模","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/566825178612568","repostId":2637331660,"repostType":2,"repost":{"id":"2637331660","kind":"highlight","weMediaInfo":{"introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"media_name":"MT Newswires Live","id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"pubTimestamp":1779370431,"share":"https://www.laohu8.com/m/news/2637331660?lang=zh_CN&edition=full","pubTime":"2026-05-21 21:33","market":"hk","language":"en","title":"Tempus AI Launches AI Powered Prostate Cancer Risk Test<blockquote>腾邦AI推出AI驱动的前列腺癌风险测试</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2637331660","media":"MT Newswires Live","summary":"Tempus AI  has launched a new prostate test for metastatic hormone-sensitive prostate cancer patients, the company said Thursday.The ArteraAI prostate test uses artificial intelligence to assess a patient's clinical data and biopsy images to estimate a patient's likelihood of prostate cancer-specific mortality, Tempus AI said.","content":"<p><html><body> <a href=\"https://laohu8.com/S/TEM\">Tempus AI</a> (TEM) has launched a new prostate test for metastatic hormone-sensitive prostate cancer patients, the company said Thursday.</p><p><blockquote><html><body><a href=\"https://laohu8.com/S/TEM\">Tempus AI</a>(TEM)周四表示，该公司已针对转移性激素敏感前列腺癌患者推出了一种新的前列腺测试。</body></html></blockquote></p><p>The ArteraAI prostate test uses artificial intelligence to assess a patient's clinical data and biopsy images to estimate a patient's likelihood of prostate cancer-specific mortality, Tempus AI said.</p><p><blockquote>Tempus AI表示，ArteraAI前列腺测试使用人工智能来评估患者的临床数据和活检图像，以估计患者前列腺癌特异性死亡率的可能性。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","source":"mtnewswires_news","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tempus AI Launches AI Powered Prostate Cancer Risk Test<blockquote>腾邦AI推出AI驱动的前列腺癌风险测试</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTempus AI Launches AI Powered Prostate Cancer Risk Test<blockquote>腾邦AI推出AI驱动的前列腺癌风险测试</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-05-21 21:33</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><body> <a href=\"https://laohu8.com/S/TEM\">Tempus AI</a> (TEM) has launched a new prostate test for metastatic hormone-sensitive prostate cancer patients, the company said Thursday.</p><p><blockquote><html><body><a href=\"https://laohu8.com/S/TEM\">Tempus AI</a>(TEM)周四表示，该公司已针对转移性激素敏感前列腺癌患者推出了一种新的前列腺测试。</body></html></blockquote></p><p>The ArteraAI prostate test uses artificial intelligence to assess a patient's clinical data and biopsy images to estimate a patient's likelihood of prostate cancer-specific mortality, Tempus AI said.</p><p><blockquote>Tempus AI表示，ArteraAI前列腺测试使用人工智能来评估患者的临床数据和活检图像，以估计患者前列腺癌特异性死亡率的可能性。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4587":"ChatGPT概念","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","BK4528":"SaaS概念","BK4588":"碎股","BK4613":"AI应用软件","AI":"C3.ai, Inc.","BK4585":"ETF&股票定投概念","LU1861558580.USD":"日兴方舟颠覆性创新基金B","TEM":"Tempus AI","BK4023":"应用软件","BK4611":"AI医疗","TEMT":"2倍做多TEM ETF-Tradr","AIYY":"YIELDMAX AI OPTION INCOME STRATEGY ETF","BK4121":"生命科学工具和服务","BK7095":"多种金属与采矿","BK4543":"AI","BK4551":"寇图资本持仓"},"source_url":"https://www.mtnewswires.com/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2637331660","content_text":"Tempus AI (TEM) has launched a new prostate test for metastatic hormone-sensitive prostate cancer patients, the company said Thursday.The ArteraAI prostate test uses artificial intelligence to assess a patient's clinical data and biopsy images to estimate a patient's likelihood of prostate cancer-specific mortality, Tempus AI said.","news_type":1,"symbols_score_info":{"TEM":1.98,"AI":0.65,"TEMT":0.6,"AIYY":0.6}},"isVote":1,"tweetType":1,"viewCount":387,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":12,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/566825178612568"}